Certara Professional Certification Program Brochure Certara 专业认证计划 Certara Professional Certification is an online accreditation of user competency and proficiency in analysis of…Certara2018 年 8 月 21 日
Clinical Pharmacology Gap Analysis: Lessons Learned Blog Clinical Pharmacology Gap Analysis: Lessons Learned Clinical pharmacology gap analysis is a tool for outlining your drug program’s needs, prioritizing these…Certara2018 年 8 月 10 日
Precision Dosing in Clinical Medicine: Present and Future Publication Precision Dosing in Clinical Medicine: Present and Future Certara2018 年 7 月 20 日
Using IVIVC to Optimize Your Drug Formulation After a Failed BA/BE Study On-Demand Webinar Using IVIVC to Optimize Your Drug Formulation After a Failed BA/BE Study This webinar introduced how IVIVC can be used to get your drug program back on…Certara2018 年 7 月 18 日
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole Publication A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole Certara2018 年 7 月 1 日
Overcoming Pitfalls and Challenges with Software Validation Blog 通过软件验证来克服陷阱和挑战 As a quality consultant and quality system subject matter expert in the Life Sciences Industry…Certara2018 年 6 月 29 日
Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data Publication Pharmacodynamic Analysis of Eribulin Safety in Breast Cancer Patients Using Real-world Postmarketing Surveillance Data Certara2018 年 6 月 22 日
Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children Publication Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children Certara2018 年 6 月 4 日
Apixaban for treatment of venous thromboembolism (VTEtx): Use of MBMA to support Phase 3 dose selection and beyond Publication Apixaban for treatment of venous thromboembolism (VTEtx): Use of MBMA to support Phase 3 dose selection and beyond Apixaban is an orally available, direct, selective inhibitor of the coagulation factor Xa that reversibly…Certara2018 年 6 月 2 日
Pharmacokinetic/ Toxicokinetic Services Brochure Pharmacokinetic/ Toxicokinetic Services As your partner for drug development and regulatory strategy, Certara has expanded its services to…Certara2018 年 5 月 18 日